< Back

MiMedx Signs Agreement with Andrews Institute

Tampa, Fla. — July 20, 2007 — MiMedx, Inc. announces today an agreement today with the Andrews Institute of Gulf Breeze, Florida to lease office space. Completed in mid-April of this year, The Andrews Institute for Orthopaedics & Sports Medicine is named for the renowned orthopedic surgeon James Andrews, MD.

The Institute's focus is musculoskeletal treatments and research, and its divisions include a Multi-specialty Ambulatory Surgery Center, Outpatient Rehabilitation, a Diagnostic Imaging Center, an Athletic Performance Center, a Research and Education Institute and a Multi-specialty Office Park for physicians. The Institute is expected to bring 150 new jobs, with nearly $10 million in wages, to Northwest Florida.

MiMedx's location at Andrews means access to world-renowned physicians, business development opportunities with numerous orthopedic companies both large and small and a potential location for clinical trials. The institute is also an ideal site for Company meetings, as Mimedx has full access to the first-rate facilities and board rooms.

About MiMedx, Inc.

Founded in 2006, MiMedx Inc. (MDX) is a development stage company whose technology focuses on biomaterials for soft tissue repair, such as tendons, ligaments and cartilage, as well as other biomaterial-based products for numerous other medical applications. The company, headquartered in Tampa, Florida, holds an exclusive, worldwide license from the Shriner's Hospital for Children and the University of South Florida Research Foundation for its NDGA technology. MDX is targeting this proprietary technology for a myriad of diverse applications.